Physician profile
Gina Simoncini
NPI 1972755544
$157,723.83
in general payments reported to CMS, 2019-2025
11 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.34 · 2020: $20K · 2021: $4,153 · 2022: $9,196 · 2023: $40K · 2024: $70K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $109K · Travel and Lodging: $12K · Food and Beverage: $3,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $108,550.00 |
| Travel and Lodging | $12,251.94 |
| Food and Beverage | $3,656.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $136,162.61 | 2020-2025 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $20,546.68 | 2019-2025 | Biktarvy, Epclusa |
| Janssen Biotech, INC. | $407.35 | 2020-2023 | Symtuza |
| Janssen Products, LP | $181.43 | 2020-2021 | |
| Abbvie INC. | $142.60 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $115.74 | 2022-2025 | Pifeltro, Delstrigo |
| Braeburn INC. | $47.07 | 2024-2025 | Brixadi |
| Theratechnologies INC. | $38.79 | 2024 | Egrifta, Trogarzo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.94 | 2024 | |
| Neurocrine Biosciences, INC. | $26.76 | 2024 | Ingrezza |
| Alkermes, INC. | $22.86 | 2024 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Simoncini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.